The quality of drug products is critical and integral for many Pharma manufacturers. It is the basis on which the relevant pharma controls, resources, activities, and growth are defined.
The Office of Pharmaceutical Quality (OPQ) within the Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research has published its 2019 Report on the State of Pharmaceutical Quality.